These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7682430)

  • 1. Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cells.
    Camplejohn RS; Brock A; Barnes DM; Gillett C; Raikundalia B; Kreipe H; Parwaresch MR
    Br J Cancer; 1993 Apr; 67(4):657-62. PubMed ID: 7682430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of prognostic significance of the monoclonal antibody Ki-S1, a novel marker of proliferative activity, in node-negative breast carcinoma.
    Bevilacqua P; Verderio P; Barbareschi M; Bonoldi E; Boracchi P; Dalla Palma P; Gasparini G
    Breast Cancer Res Treat; 1996; 37(2):123-33. PubMed ID: 8750580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical staining of DNA topoisomerase IIalpha in human gliomas.
    Taniguchi K; Wakabayashi T; Yoshida T; Mizuno M; Yoshikawa K; Kikuchi A; Nakashima N; Yoshida J
    J Neurosurg; 1999 Sep; 91(3):477-82. PubMed ID: 10470824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-S1 and PCNA expression in erythroid precursors and megakaryocytes--a comparative study on proliferative and endoreduplicative activity in reactive and neoplastic bone marrow lesions.
    Thiele J; Bertsch HP; Kracht LW; Anwander T; Zimmer JD; Kreipe H; Fischer R
    J Pathol; 1994 May; 173(1):5-12. PubMed ID: 7523642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric characterisation of proliferating cell nuclear antigen using the monoclonal antibody PC10.
    Wilson GD; Camplejohn RS; Martindale CA; Brock A; Lane DP; Barnes DM
    Eur J Cancer; 1992; 28A(12):2010-7. PubMed ID: 1358156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of different methods for determination of proliferative activity of breast carcinomas].
    Mink D; Villena-Heinsen C; Tossounidis I; Schmidt W
    Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():53-6. PubMed ID: 8672927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
    Yu CC; Dublin EA; Camplejohn RS; Levison DA
    Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast.
    Ostrowski ML; Chakraborty S; Laucirica R; Brown RW; Greenberg SD
    Anal Quant Cytol Histol; 1995 Feb; 17(1):15-24. PubMed ID: 7766265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparameter absorption measurements in automated microscopy. Simultaneous quantitative determination of DNA and nuclear antigen.
    Oud PS; Bauwens A; Nauwelaers FA
    Acta Cytol; 1997; 41(1):188-96. PubMed ID: 9022743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the cell cycle-associated monoclonal antibody Ki-S1 as a prognostic factor in primary invasive adenocarcinoma of the breast.
    Morris ES; Elston CW; Bell JA; Galea M; Blamey RW; Ellis IO
    J Pathol; 1995 May; 176(1):55-62. PubMed ID: 7616357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining.
    van Dierendonck JH; Wijsman JH; Keijzer R; van de Velde CJ; Cornelisse CJ
    Am J Pathol; 1991 May; 138(5):1165-72. PubMed ID: 1673821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
    Siitonen SM; Kallioniemi OP; Isola JJ
    Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIB1 proliferation index in breast infiltrating carcinoma: comparison with other proliferative markers and association with new biological prognostic factors.
    González-Vela MC; Garijo MF; Fernández F; Val-Bernal JF
    Histol Histopathol; 2001 Apr; 16(2):399-406. PubMed ID: 11332695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas.
    Ellis PA; Makris A; Burton SA; Titley J; Ormerod MG; Salter J; Powles TJ; Smith IE; Dowsett M
    Br J Cancer; 1996 Mar; 73(5):640-3. PubMed ID: 8605100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor proliferative fraction in solid malignant neoplasms. A comparative study of Ki-67 immunostaining and flow cytometric determinations.
    Sahin AA; Ro JY; el-Naggar AK; Wilson PL; Teague K; Blick M; Ayala AG
    Am J Clin Pathol; 1991 Oct; 96(4):512-9. PubMed ID: 1716414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric multiparameter analysis of proliferating cell nuclear antigen/cyclin and Ki-67 antigen: a new view of the cell cycle.
    Landberg G; Tan EM; Roos G
    Exp Cell Res; 1990 Mar; 187(1):111-8. PubMed ID: 1967582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative activity in invasive breast carcinoma: a comprehensive comparison of MIB-1 immunocytochemical staining in aspiration biopsies to image analytic, flow cytometric and histologic parameters.
    Ostrowski ML; Pindur J; Laucirica R; Chakraborty S; Ramzy I
    Acta Cytol; 2001; 45(6):965-72. PubMed ID: 11726126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry.
    Dawson AE; Norton JA; Weinberg DS
    Am J Pathol; 1990 May; 136(5):1115-24. PubMed ID: 1972000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between Ki-67 index and S-phase fraction on fine-needle aspiration samples from breast carcinoma.
    Bozzetti C; Nizzoli R; Camisa R; Guazzi A; Ceci G; Cocconi G; Mazzini G; Naldi N
    Cancer; 1997 Oct; 81(5):287-92. PubMed ID: 9349516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of resting cells by dual-parameter flow cytometry of statin expression and DNA content.
    Pellicciari C; Mangiarotti R; Bottone MG; Danova M; Wang E
    Cytometry; 1995 Dec; 21(4):329-37. PubMed ID: 8608730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.